Intraocular Lens

When we perform cataract surgery for patients with retinal disease, we must tailor the IOL type, design and power to maximize vision given the underlying pathology.

The launch of a new IOL and strategies to allay patients’ fears led cataract surgery coverage in January.

Femtosecond lasers offer us the opportunity to create a fast, centered capsulotomy more effectively than is possible in a manual procedure.

Ultrasert is the name of Alcon’s delivery system for its preloaded AcrySof IQ IOLs. These lenses arrive already packaged inside their injector and need only priming with viscoelastic before delivery.

In this video exclusive, Rajesh K. Rajpal, MD, chief medical officer and global head of clinical and medical affairs at Johnson & Johnson Vision, discusses the recent FDA approvals of the Tecnis Eyhance and Eyhance toric II IOLs.

The FDA approved the Tecnis Eyhance and Tecnis Eyhance toric II IOLs for the treatment of patients with cataract, according to a press release.

There has been quite an evolution of IOLs since their inception. In the era of refractive cataract surgery, there is an increasing demand for a full range of vision without visual aids including glasses or contact lenses.

We now have three excellent FDA-approved laser methods to treat myopia, hyperopia and astigmatism in PRK, LASIK and SMILE.

LASIK, PRK and SMILE can all provide positive long-term vision results, but advancements in corneal and lens-based refractive surgery are enabling the optimization of vision for an even wider group of patients.

Easily exchangeable IOLs and more advanced accommodating IOLs may be on the horizon for presbyopia management, according to speakers on the clinical panel at the virtual Ophthalmology Innovation Summit Presbyopia Innovation Showcase.